Abstract
The field of biotechnology instrumentation has been an expanding one ever
since the emergence of the Human Genome Project 20 years ago. Although the
filed certainly existed prior to that point in time, it was the Human Genome
Project with its major access to key universities, national laboratories, and
government funding sources that gave great acceleration to the field. There
are several technologies applicable to genomic and proteomic analysis, all of
which have become important to the nature of the field. All are capable of
providing information essential to various aspects of biotechnological
testing. Some of these technologies are integral; others are ancillary. Some
are widely used; others are not. Some are highly adaptable to automation (or
are essentially automation technologies); others are less so. The issue
regarding all of these technologies is whether or not their status as
automated, instrumented technologies, will change over the next ten years.
This report focuses on the development of advanced biotechnology
instrumentation technology including the following key areas:
- Chromatography (specifically HPLC)
- Electrophoresis
- Microarray Technology
- Immunoassay
- Imaging
- Mass Spectrometry
The major market effects of new and advanced biotechnology analysis
instrumentation are currently being seen in product life extension efforts and
will be seen with greater impact in the five to ten years. This report
considers the options that the current technologies present, the progress that
is being made in these fields, and the reception these new products are likely
to experience in the marketplace. The report focuses on the applications of
advanced biotechnology instrumentation, the improvements expected in existing
instrumentation, and the facilitation of the delivery and commercialization of
new analysis technologies and instrumentation.
For each instrumentation area, the report provides:
- a review of existing methods and applications
- key suppliers and their technologies
- a discussion of the technical and strategic future of the field
In addition, extensive, in-depth profiles of ten players--representing a
diverse cross-section of instrument suppliers--and eight conclusions with
strategic implications round out this considered analysis of a dynamic and
underexamined field.
The analysis presented in this report is based on data from a combination of
company, government, industrial, institutional and private sources. It
includes information from extensive literature reviews, as well as interviews
and discussions with experts in the field, including experts in genomic and
proteomic analysis, as well business development and marketing managers
engaged in the field.
View Cart
